World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
46425
World Ranking
6468
National Ranking
247

Wouter W. de Herder publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Wouter W. de Herder sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 548 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Wouter W. de Herder D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Wouter W. de Herder sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Wouter W. de Herder is affiliated with Erasmus University Rotterdam in the Netherlands and has contributed extensively to the field of medical research, with a focus on neuroendocrine tumors and related oncology disciplines. Their research spans several interconnected areas within medicine, emphasizing neurological and endocrine aspects of cancer and metabolism.

Their primary fields of study include Medicine, with significant work in the subfields of Epidemiology, Oncology, Neurology, Endocrinology, Diabetes and Metabolism, and Surgery. These fields underline the multidisciplinary nature of their research interests and expertise.

Wouter W. de Herder's main topics of scientific inquiry cover a range of areas, including:

  • Neuroendocrine Tumor Research Advances
  • Lung Cancer Research Studies
  • Neuroblastoma Research and Treatments
  • Pancreatic and Hepatic Oncology Research
  • Pituitary Gland Disorders and Treatments
  • Growth Hormone and Insulin-like Growth Factors
  • Gastrointestinal Tumor Research and Treatment

The scientist has published articles frequently in venues such as:

  • Endocrine Related Cancer
  • The Journal of Clinical Endocrinology & Metabolism
  • Endocrinologie
  • Journal of Neuroendocrinology
  • Journal of Endocrinological Investigation

Among the recent papers associated with the broader research context relevant to their work are:

  • "Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms," 2022, Endocrine Pathology
  • "[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study," 2024, The Lancet
  • "Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up," 2021, Annals of Oncology
  • "Consensus on molecular imaging and theranostics in neuroendocrine neoplasms," 2021, European Journal of Cancer
  • "High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma," 2021, Clinical Cancer Research

Frequent collaborators who have worked alongside Wouter W. de Herder include:

  • Johannes Hofland
  • Richard A. Feelders
  • Tessa Brabander
  • Wouter T. Zandee
  • Marie-Louise F. van Velthuysen

Wouter W. de Herder's research profile outlines a consistent commitment to advancing understanding in neuroendocrine tumor biology, diagnostic and therapeutic strategies in oncology, and related metabolic disorders. The breadth and depth of their publications reflect interdisciplinary approaches linking clinical practices with molecular and epidemiological insights within medicine.

Best Publications

  • Gastroenteropancreatic neuroendocrine tumours.

    Irvin M Modlin;Kjell Oberg;Daniel C Chung;Robert T Jensen

  • TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

    G. Rindi;G. Klöppel;H. Alhman;M. Caplin

  • Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

    Dik J. Kwekkeboom;Wouter W. de Herder;Boen L. Kam;Casper H. van Eijck

  • Drug therapy : octreotide

    A. J. J. Wood;S. W. J. Lamberts;A.-J. Van Der Lely;W. W. De Herder

  • Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

    Dik J. Kwekkeboom;Jaap J. Teunissen;Willem H. Bakker;Peter P. Kooij

  • Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system

    Kjell Öberg;L. Kvols;M. Caplin;G. Dell Fave

  • Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

    Martyn E. Caplin;E. Baudin;P. Ferolla;P. Filosso

  • NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

    Matthew H. Kulke;Lowell B. Anthony;David L. Bushnell;Wouter W. de Herder

  • An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.

    Francien H van Nederveen;José Gaal;Judith Favier;Esther Korpershoek

  • ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.

    Robert T. Jensen;Guillaume Cadiot;Maria L. Brandi;Wouter W. de Herder

  • Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

    U. Plöckinger;G. Rindi;R. Arnold;B. Eriksson

  • Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

    Tessa Brabander;Wouter A. van der Zwan;Jaap J.M. Teunissen;Boen L.R. Kam

  • Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience

    Roelf Valkema;Marion de Jong;Willem H. Bakker;Wout A.P. Breeman

  • Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

    Dik J Kwekkeboom;Boen L Kam;Martijn van Essen;Jaap J M Teunissen

  • Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.

    F. R. E. Nobels;D. J. Kwekkeboom;W. Coopmans;C. H. H. Schoenmakers

  • Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0, Tyr3]octreotate

    D. J. Kwekkeboom;W. H. Bakker;B. L. Kam;J. J. M. Teunissen

  • ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.

    G. Delle Fave;D. O'Toole;Anders Sundin;B. Taal

  • TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study

    Guido Rindi;M Falconi;C Klersy;L Albarello

  • ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.

    Rodney J Hicks;Dik J Kwekkeboom;Eric Krenning;Lisa Bodei

  • Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study

    Adrian F. Daly;Maria A. Tichomirowa;Patrick Petrossians;Elina Heliövaara

Frequent Co-Authors

Leo J. Hofland
Leo J. Hofland Erasmus University Rotterdam
Steven W. J. Lamberts
Steven W. J. Lamberts Erasmus University Rotterdam
Dik J. Kwekkeboom
Dik J. Kwekkeboom Erasmus University Rotterdam
Eric P. Krenning
Eric P. Krenning Erasmus University Rotterdam
Gregory Kaltsas
Gregory Kaltsas National and Kapodistrian University of Athens
Olaf M. Dekkers
Olaf M. Dekkers Leiden University Medical Center
Casper H.J. van Eijck
Casper H.J. van Eijck Erasmus University Rotterdam
Ronald R. de Krijger
Ronald R. de Krijger Erasmus University Rotterdam
Diego Ferone
Diego Ferone University of Genoa
Massimo Falconi
Massimo Falconi Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in Medicine but seeking flexible or alternative pathways, there are several related online degree options available. Many healthcare careers—such as nursing, nurse practitioner, and medical coding—now offer accredited programs that can be completed fully online, making them more accessible and affordable.

Those considering administrative roles might explore medical billing and coding online courses cost as a starting point. These programs tend to be shorter and can quickly lead to job opportunities in hospitals or clinics.

For aspiring nurses, there are a variety of affordable online pathways. Research the cheapest np school online options if you’re aiming to become a nurse practitioner, or consider the cheapest bsn programs online to earn your bachelor's degree in nursing.

Education doesn’t have to stop at the bachelor’s or master’s level. Ambitious students can even pursue a doctorate through the cheapest dnp programs online, preparing for leadership roles in healthcare innovation, education, and policy.

Best Scientists Citing Wouter W. de Herder

Trending Scientists

Recently Published Articles